Culture media alter retinal organoid physiology promoting AAV transduction and retinal ganglion cell survival

The observation that culture media composition can reshape the physiology of retinal organoids carries implications that extend well beyond the immediate experimental findings. Retinal organoids are three-dimensional structures derived from pluripotent stem cells that recapitulate, to a remarkable degree, the developmental choreography of the human retina. Over weeks and months in culture, these self-organizing tissues progress through stages that mirror embryonic retinogenesis: early optic vesicle-like structures emerge, retinal progenitor cells proliferate in a ventricular-like zone, and successive waves of differentiation generate the major retinal cell classes in the same order observed in vivo, with retinal ganglion cells appearing first, followed by horizontal cells, amacrine cells, and cone photoreceptors, and finally rod photoreceptors and Müller glia. Because this sequence depends on intrinsic developmental programs as well as extrinsic environmental cues, the composition of the culture medium is not a passive backdrop but an active participant in determining which programs proceed, at what pace, and with what fidelity.

Standard organoid culture media typically include a basal formulation such as DMEM/F12 supplemented with factors that promote neural differentiation, including N2 and B27 supplements, and often retinoic acid at later stages to encourage photoreceptor maturation. Variations among laboratories in the choice of basal medium, the concentration of supplements, the presence or absence of serum components, and the timing of factor additions have long been recognized as sources of heterogeneity, but the systematic consequences of these choices for downstream applications have been less thoroughly characterized. The finding that media alter both adeno-associated virus transduction and retinal ganglion cell survival suggests that seemingly minor formulation differences can propagate into functional outcomes that matter enormously for translational work.

Adeno-associated virus vectors are the leading platform for retinal gene therapy, with approved products demonstrating that subretinal or intravitreal delivery can produce durable clinical benefit in inherited retinal degenerations. The success of AAV-mediated gene transfer depends on a cascade of events: vector particles must reach the target cells, bind to cell surface receptors, undergo endocytosis, traffic through the cytoplasm, enter the nucleus, uncoat, and convert their single-stranded genome into a transcriptionally competent double-stranded form. Each step can be influenced by the physiological state of the target cell, including membrane composition, endosomal trafficking dynamics, proteasome activity, and the expression of factors that second-strand synthesis. If culture media shift cells into states that favor or hinder any of these steps, then organoid-based assessments of vector tropism and potency will yield results that are artifacts of the culture condition rather than faithful predictions of clinical behavior.

This consideration is particularly acute because organoids are increasingly used as preclinical screening platforms for vector engineering. Researchers seeking capsids with improved photoreceptor tropism, or with the ability to penetrate the inner limiting membrane after intravitreal injection, frequently validate their designs in retinal organoids before advancing to animal studies. A capsid that appears highly efficient in organoids maintained in one medium might underperform in organoids maintained in another, not because the capsid has changed but because the cellular context has. Standardizing media composition, or at minimum reporting it comprehensively and testing key findings across multiple formulations, would strengthen the predictive value of such screens and reduce the risk of pursuing vector designs whose apparent advantages do not survive a change of culture conditions.

The effects on retinal ganglion cell survival are equally consequential. Retinal ganglion cells are the projection neurons of the visual system, conveying visual information from the retina to the brain through the optic nerve, and their degeneration underlies glaucoma and other optic neuropathies. In organoid culture, ganglion cells are notoriously fragile; they are among the first cell types generated, they reside in the innermost layer of the tissue, and they depend on trophic support that is difficult to reproduce in a dish. Their progressive loss during long-term organoid culture is a well-documented limitation, and it complicates any effort to model ganglion cell diseases or to test neuroprotective strategies. If specific medium components can substantially extend ganglion cell survival, this opens two important avenues: first, the creation of longer-lived organoid models in which disease-relevant cell types remain available for study; and second, the identification of the trophic factors and metabolic conditions that ganglion cells require, which may themselves point toward therapeutic targets.

The mechanistic links between medium composition and cell survival likely involve several intersecting pathways. Oxidative stress is a prominent candidate, since retinal neurons are metabolically demanding and vulnerable to reactive oxygen species, and the antioxidant capacity of medium supplements such as those in B27 varies with formulation and with the degradation of components over time in culture. Energy metabolism is another: the retina is among the most oxygen-consuming tissues in the body, and photoreceptors in particular rely on aerobic glycolysis, a metabolic mode whose support depends on glucose and pyruvate availability in the medium. Growth factor signaling, including pathways involving BDNF, CNTF, GDNF, and insulin-like growth factors, also modulates ganglion cell survival, and the presence, stability, and concentration of such factors differ across media formulations. Even the buffering system and the resulting pH stability can influence neuronal health, as can osmolarity and the accumulation of metabolic waste products between medium changes.

For AAV transduction specifically, medium composition might act through effects on the cell surface. The glycocalyx, the dense layer of sugars coating the plasma membrane, provides attachment points that many AAV seruses exploit, and its composition is sensitive to culture conditions, including the availability of specific sugars and the activity of glycosyltransferases. Heparan sulfate proteoglycans serve as primary attachment receptors for several AAV serotypes, and sialic acid residues are critical for others. Media that alter glycosaminoglycan synthesis or sialylation could therefore change the efficiency of the initial binding step. Downstream, intracellular trafficking depends on the cytoskeleton and on endosomal pH, both of which can be modulated by medium components such as ammonium chloride accumulation, chloroquine-like compounds, or simply the energetic state of the cell. These mechanisms offer plausible, testable explanations for how the same vector applied to the same organoid type can perform differently across media.

The broader lesson resonates with a recurring theme in stem cell biology: the environment is part of the experiment. Organoids are often described as miniaturized versions of human tissues, but they are better understood as products of a continuous dialogue between intrinsic developmental programs and the culture environment. Small differences in oxygen tension, media exchange schedules, matrix composition, and the physical handling of cultures have all been shown to affect organoid morphology and cell type composition. The present findings add media formulation to this list in a way that directly touches two of the most translationally important readouts: gene delivery efficiency and survival of a clinically critical neuron.

From a practical standpoint, laboratories working with retinal organoids for gene therapy applications should consider several measures. Detailed documentation of medium composition, including lot numbers of supplements whose activity varies between batches, would improve reproducibility across the field. Cross-validation of key results in at least two distinct media formulations would reveal whether findings are robust or condition-dependent. Where possible, matching the metabolic and trophic environment of the organoid to the physiological state of the target tissue in vivo would improve the clinical relevance of preclinical testing. For ganglion cell studies specifically, optimizing media for survival may need to be balanced against the goal of photoreceptor maturation, since conditions that favor one cell class may not favor another, and the developmental timing of these requirements may differ.

There are also implications for disease modeling. Many inherited retinal diseases are cell-type specific, and the value of an organoid model depends on maintaining the relevant cells in a state that resembles their in vivo counterpart. Ganglion cell loss in culture has limited the use of organoids for modeling optic neuropathies such as those caused by mutations in OPA1 or other genes affecting mitochondrial function. If optimized media extend ganglion cell survival substantially, models of these diseases become feasible, enabling the study of pathogenesis in a human developmental context and the screening of candidate neuroprotective compounds. Similarly, for glaucoma research, where the interplay between elevated intraocular pressure, axonal transport disruption, and somal survival is difficult to disentangle in animal models, longer-lived organoid systems with robust ganglion cell populations would provide a complementary human platform.

The intersection with AAV biology deserves particular attention as the gene therapy field matures. Dose-limiting toxicity, immune responses, and the challenge of achieving pan-retinal transduction after intravitreal delivery remain central obstacles. Organoids offer a human-relevant system in which to evaluate candidate capsids, promoters, and expression cassettes, but their utility depends on the transduction results reflecting what would occur in a patient retina. The finding that media promote or suppress transduction suggests that part of the variability reported across organoid studies of AAV tropism may be attributable to culture conditions rather than to genuine differences in vector performance. Disentangling these variables will require systematic comparisons in which identical vectors are applied to organoids raised in parallel under different media conditions, with careful quantification of both transduction efficiency and the cell-type composition of the tissues.

It is also worth considering how these findings fit into the larger regulatory and manufacturing landscape. As retinal organoids move toward use in potency assays and release testing for cell and gene therapy products, the dependence of their properties on media composition becomes a matter of product consistency. Regulatory frameworks emphasize the characterization of critical quality attributes, and for organoid-based assays, the culture medium is arguably a critical reagent whose composition must be controlled with the same rigor as the biological material itself. Manufacturers of media and supplements may need to provide more detailed specifications, and users may need to implement qualification procedures for each new lot, particularly for supplements such as B27 whose complex composition includes components with variable biological activity.

Looking forward, the systematic mapping of how individual medium components affect retinal organoid physiology could yield a design framework for culture conditions tailored to specific applications: media optimized for photoreceptor maturation for studies of inherited photoreceptor degenerations, media optimized for ganglion cell survival for optic neuropathy models, and media that support efficient AAV transduction for vector validation studies. Such an approach would treat the medium as an engineering variable rather than a fixed convention, transforming a source of uncontrolled variability into a tool for shaping organoid properties. The present work, by demonstrating that culture media alter both AAV transduction and retinal ganglion cell survival in retinal organoids, provides both a caution about the interpretation of existing organoid studies and a constructive starting point for this more deliberate approach to organoid culture design.

Subject of Research: Culture media alter retinal organoid physiology promoting AAV transduction and retinal ganglion cell survival

Article Title: Culture media alter retinal organoid physiology promoting AAV transduction and retinal ganglion cell survival

Article References: O’Hara-Wright, M., Lim, B. Y., M. Mangala, M., Kaiser, V., Wong, E., Aubin, D., Nemeruck, V., Reynisson, H., Doroudian, F., Chan, O. P. Y., Aryamanesh, N., A. Paulo, J., Palomba, S., Mirzaei, M., Ginn, S. L., & Gonzalez-Cordero, A. (2026). Culture media alter retinal organoid physiology promoting AAV transduction and retinal ganglion cell survival. Gene Therapy. https://doi.org/10.1038/s41434-026-00642-0

Image Credits: AI Generated

DOI: 10.1038/s41434-026-00642-0

Keywords: Culture, media, alter, retinal, organoid, physiology, promoting, transduction, ganglion, cell, survival, scientific research